Goldman Sachs’s Vivani Medical VANI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-14,423
| Closed | -$18.6K | – | 6663 |
|
|
2025
Q2 | $18.6K | Buy |
+14,423
| New | +$15.9K | ﹤0.01% | 5987 |
|
|
2022
Q4 | – | Sell |
-21,267
| Closed | -$48K | – | 6286 |
|
|
2022
Q3 | $48K | Buy |
21,267
+11,479
| +117% | +$54.5K | ﹤0.01% | 5804 |
|
|
2022
Q2 | $60K | Sell |
9,788
-2,031
| -17% | -$10.9K | ﹤0.01% | 5993 |
|
|
2022
Q1 | $51K | Buy |
11,819
+502
| +4% | +$2.11K | ﹤0.01% | 6270 |
|
|
2021
Q4 | $55K | Buy |
11,317
+3,091
| +38% | +$22.6K | ﹤0.01% | 6249 |
|
|
2021
Q3 | $79K | Buy |
+8,226
| New | +$92.6K | ﹤0.01% | 5954 |
|
|
2021
Q2 | – | Sell |
-4,384
| Closed | -$109K | – | 6536 |
|
|
2021
Q1 | $109K | Buy |
+4,384
| New | +$65.4K | ﹤0.01% | 5821 |
|
|
2019
Q4 | – | Sell |
-656
| Closed | -$13K | – | 5418 |
|
|
2019
Q3 | $13K | Sell |
656
-62
| -9% | -$1.22K | ﹤0.01% | 5121 |
|
|
2019
Q2 | $14K | Sell |
718
-363
| -34% | -$7.44K | ﹤0.01% | 5070 |
|
|
2019
Q1 | $21K | Buy |
1,081
+187
| +21% | +$3.64K | ﹤0.01% | 5049 |
|
|
2018
Q4 | $19K | Sell |
894
-363
| -29% | -$11.6K | ﹤0.01% | 5154 |
|
|
2018
Q3 | $57K | Buy |
1,257
+93
| +8% | +$3.75K | ﹤0.01% | 5268 |
|
|
2018
Q2 | $46K | Sell |
1,164
-10
| -0.9% | -$435 | ﹤0.01% | 5370 |
|
|
2018
Q1 | $54K | Sell |
1,174
-265
| -18% | -$11.8K | ﹤0.01% | 5458 |
|
|
2017
Q4 | $66K | Buy |
1,439
+347
| +32% | +$11.5K | ﹤0.01% | 5873 |
|
|
2017
Q3 | $31K | Sell |
1,092
-1,874
| -63% | -$52.4K | ﹤0.01% | 6360 |
|
|
2017
Q2 | $90K | Buy |
2,966
+2,419
| +442% | +$68.4K | ﹤0.01% | 6163 |
|
|
2017
Q1 | $16K | Buy |
+547
| New | +$21K | ﹤0.01% | 6560 |
|
|
2016
Q3 | – | Sell |
-5,021
| Closed | -$431K | – | 7198 |
|
|
2016
Q2 | $431K | Buy |
5,021
+2,148
| +75% | +$224K | ﹤0.01% | 4987 |
|
|
2016
Q1 | $333K | Buy |
2,873
+1,450
| +102% | +$167K | ﹤0.01% | 5165 |
|
|
2015
Q4 | $201K | Sell |
1,423
-2,322
| -62% | -$340K | ﹤0.01% | 5709 |
|
|
2015
Q3 | $533K | Buy |
3,745
+2,697
| +257% | +$749K | ﹤0.01% | 5078 |
|
|
2015
Q2 | $342K | Sell |
1,048
-494
| -32% | -$158K | ﹤0.01% | 5608 |
|
|
2015
Q1 | $474K | Sell |
1,542
-578
| -27% | -$161K | ﹤0.01% | 5188 |
|
|
2014
Q4 | $522K | Buy |
+2,120
| New | +$739K | ﹤0.01% | 5240 |
|
Other funds holding VANI
Goldman Sachs's VANI Position: Q3 2025 in Review
Goldman Sachs sold out of Vivani Medical (VANI) in Q3 2025, closing a stake of 14,423 shares — an estimated $18.6K sold.
Goldman Sachs first reported a position in VANI in Q4 2014 and held it in 25 quarters. The position peaked at $533K in Q3 2015. 29 funds tracked by Wall St. Rank hold VANI as of Q3 2025.
- Goldman Sachs reported no remaining Vivani Medical position as of Q3 2025 after selling out during the quarter.
- Goldman Sachs sold 14,423 Vivani Medical shares in Q3 2025, an estimated $18.6K.
- Goldman Sachs first reported a position in Vivani Medical in Q4 2014 and held it in 25 quarters.
- Goldman Sachs's Vivani Medical position peaked at $533K in Q3 2015.
- 29 funds tracked by Wall St. Rank held Vivani Medical as of Q3 2025.
Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.